Administrative Core

项目摘要/摘要 梅奥诊所多发性骨髓瘤孢子(孢子)管理核心的总体目标是刺激 研究骨髓瘤，并加快将发现转化为新的更好的预防方法， 骨髓瘤的检测和治疗。行政管理核心一直是 孢子在上一次资助期间。在下一个授权期内，它将继续提供 旨在协调研究项目、科学核心和 发展计划(发展研究计划、职业提升计划)。这个 行政核心将负责协调孢子委员会的职能，包括 执行委员会、外部咨询委员会和患者权益倡导组织。Leif Bergsagel博士 文森特·拉伊库马尔将担任行政核心的联席主任。Bergsagel和Rajkumar 在之前的资助期间，作为一个团队运作良好，并将继续通力合作，提供 对孢子活动的监督。行政核心将： 1)为孢子调查员提供领导、组织支持和财务管理 2)协调亚利桑那州、罗切斯特市和佛罗里达州梅奥诊所之间的沟通和合作， 包括支持调查人员之间交流意见、设计新项目、开展 翻译研究和翻译研究成果的报告 3)向科学界和公众提供信息传输 4)为与外部咨询委员会的互动提供领导和组织支持，如 以及孢子研究项目的外部和内部审查 5)提供建立和培育合作的结构，以促进和扩大合作 骨髓瘤研究包括Mayo位点之间的相互作用 6)与孢子患者倡导者密切合作，使他们了解孢子的进展，以及 促进他们在所有级别提供投入的能力 7)培养青年调查员发展 8)与NCI沟通。

PROJECT SUMMARY/ABSTRACT The overall goal of the Mayo Clinic Multiple Myeloma SPORE (SPORE) Administration Core is to stimulate research in myeloma and to expedite the translation of discoveries into new and better methods of prevention, detection, and treatment of myeloma. The Administration Core has served well as the organizational hub of SPORE during the prior funding period. During the next grant period, it will continue to provide an organizational structure designed to coordinate the activities of the research projects, scientific cores, and developmental programs (Developmental Research Program, Career Enhancement Program). The Administration Core will be responsible for coordinating the function of the SPORE committees including the Executive Committee, the External Advisory Committee, and the Patient Advocate Group. Drs. Leif Bergsagel and Vincent Rajkumar will serve as Co-Directors of the Administration Core. Bergsagel and Rajkumar functioned well as a team during the prior funding period, and will continue to work collaboratively to provide oversight of SPORE activities. The Administration Core will: 1) Provide leadership, organizational support, and financial management for SPORE investigators 2) Coordinate communication and collaboration between Mayo Clinic Arizona, Rochester and Florida, including support for exchange of ideas between investigators, design of new projects, conduct of translational research, and reporting of translational research findings 3) Provide information transfer to the scientific community and the public 4) Provide leadership and organizational support for interactions with the External Advisory Committee, as well as external and internal review for SPORE research projects 5) Provide the structure for the establishment and nurture of collaborations to facilitate and expand myeloma research including interactions between Mayo sites 6) Work closely with SPORE patient advocates so that they are aware of the progress of the SPORE, and facilitate their ability to provide input at all levels 7) Foster young investigator development 8) Communicate with the NCI.